Press Releases

Press Releases

    Date Title View
    12/17/15
    Summary ToggleHorizon Pharma plc to Present at the 34th Annual J.P. Morgan Healthcare Conference
    12/14/15
    Summary ToggleHorizon Pharma plc and Fox Chase Cancer Center Temple Health Initiate Phase 1 Study to Evaluate ACTIMMUNE(R) (interferon gamma-1b) in Combination With Nivolumab in Patients With Advanced Solid Tumors
    12/11/15
    Summary ToggleHorizon Pharma plc to Acquire Crealta Holdings LLC in All Cash Acquisition
    12/01/15
    Summary ToggleHorizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering PENNSAID(R) 2%
    11/30/15
    Summary ToggleHorizon Pharma plc Receives European Commission Approval for RAVICTI(R) (glycerol phenylbutyrate) Oral Liquid for the Treatment of Urea Cycle Disorders in Patients Two Months of Age and Older
    11/19/15
    Summary ToggleHorizon Pharma plc Withdraws Offer to Acquire Depomed, Inc.
    11/19/15
    Summary ToggleHorizon Pharma plc to Present at Two Conferences in December
    11/13/15
    Summary ToggleHorizon Pharma plc Provides Update on Shareholders Meeting Related to the Proposed Acquisition of Depomed, Inc.
    11/13/15
    Summary ToggleHorizon Pharma plc Selected as One of Chicago Tribune's Top Workplaces in 2015
    11/13/15
    Summary ToggleHorizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO(R) (naproxen/esomeprazole) Delayed Release Tablets
    Displaying 1 - 10 of 96 results